Projects per year
Fingerprint
Dive into the research topics where Joerg Herrmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
3/1/19 → 2/28/25
Project: Research project
-
Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy
Jacobs, J. E. J., Greason, G., Mangold, K. E., Wildiers, H., Willems, R., Janssens, S., Noseworthy, P., Lopez-Jimenez, F., Voigt, J. U., Friedman, P., Van Aelst, L., Vandenberk, B., Attia, Z. I. & Herrmann, J., Mar 1 2024, In: European Journal of Preventive Cardiology. 31, 5, p. 560-566 7 p.Research output: Contribution to journal › Article › peer-review
-
Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia
Christopoulos, G., Attia, Z. I., Achenbach, S. J., Rabe, K. G., Call, T. G., Ding, W., Leis, J. F., Muchtar, E., Kenderian, S. S., Wang, Y., Hampel, P. J., Koehler, A. B., Kay, N. E., Kapoor, P., Slager, S. L., Shanafelt, T. D., Noseworthy, P. A., Friedman, P. A., Herrmann, J. & Parikh, S. A., Apr 2024, In: JACC: CardioOncology. 6, 2, p. 251-263 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?
Abbasi, M. A., El-Am, E., Geske, J. B. & Herrmann, J., Feb 2024, In: Mayo Clinic proceedings. 99, 2, p. 191-193 3 p.Research output: Contribution to journal › Editorial › peer-review
-
Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide
Hazim, A., Nhola, L. F., Kailash, V., Zhang, S., Sandhu, N. P., Lerman, A., Loprinzi, C. L., Ruddy, K. J., Villarraga, H. R., Lewis, B. & Herrmann, J., Jan 1 2024, In: European Heart Journal Open. 4, 1, oead130.Research output: Contribution to journal › Article › peer-review
Open Access -
Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis: Therapeutic Targets in Atherosclerosis?
Nitz, K., Herrmann, J., Lerman, A. & Lutgens, E., 2024, (Accepted/In press) In: JACC: Basic to Translational Science.Research output: Contribution to journal › Review article › peer-review
Open Access